They applied triple malignant brain tumor domains (3×MBT) of Lethal(3)malignant brain tumor-like protein 1 (L3MBTL1) to bind Kme1 and Kme2 and improved MS-based identification of methylated proteins (Figure 3A). This evidence concerns the gene L3MBTL1 and brain neoplasm.